Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Treatment Patterns and Healthcare Resource Utilization in Patients with Multiple Myeloma and Baseline Renal Impairment

Parameswaran Hari, MD MRCP, Lita Araujo, Dominick Latremouille-Viau, MSc, Peggy Lin, PhD, Mikhail Davidson, Annie Guerin, MSc, Medha Sasane

Blood (2020) 136 (Supplement 1): 17–18.

https://doi.org/10.1182/blood-2020-134597

Published: 2020

Journal Articles

Epidemiologic and Clinical Characteristics of Thalassemia (Thal) Intermedia (TI) in the United States

Elliott P. Vichinsky, MD, Janet Kwiatkowski, MD, Patricia J. Giardina, MD, Carole Paley, MD, Francis Vekeman, MA, Wendy Y. Cheng, MPH, MPhil, Joseph Damron, BA, Nora McCormick, MSc, Medha Sasane, PhDBPharm,MS, Ying Qiu, PhD, Mei Sheng Duh, MPH, ScD, Alexis A. Thompson, MD

Blood (2015) 126 (23): 3279.

https://doi.org/10.1182/blood.V126.23.3279.3279

Published: 2015

Journal Articles

Adherence to Iron Chelation Therapy and Associated Healthcare Resource Utilization and Costs in Medicaid Patients with Sickle Cell Disease

Francis Vekeman, MA, Medha Sasane, BPharm, PhD, Wendy Y Cheng, MPH, MPhil, Agnihotram V Ramanakumar, PhD, Jonathan Fortier, MA, Mei S. Duh, ScD, MPH, Carole Paley, MD, Patricia Adams-Graves, MD

Blood (2014) 124 (21): 2177.

https://doi.org/10.1182/blood.V124.21.2177.2177

Published: 2014

Journal Articles

Medical Complications In Patients With Myelofibrosis By Frequency Of Blood Transfusion and Iron Chelation Therapy

Francis Vekeman, MA, Wendy Y Cheng, MPH, MPhil, Medha Sasane, BPharm, PhD, Lynn Huynh, MPH, MBA, DrPH, Michael Kaminsky, BA, Mei S. Duh, ScD, MPH, Carole Paley, MD, Ruben A. Mesa, MD

Blood (2013) 122 (21): 2964.

https://doi.org/10.1182/blood.V122.21.2964.2964

Published: 2013

Journal Articles

Transition From Pediatric To Adult Care Of High Cost Patients In a Medicaid Population With Sickle Cell Disease

Morey A. Blinder, MD, Medha Sasane, BPharm, PhD, Jonathan Fortier, MA, Carole S. Paley, MD, Mei S. Duh, ScD, MPH, Francis Vekeman, MA

Blood (2013) 122 (21): 2927.

https://doi.org/10.1182/blood.V122.21.2927.2927

Published: 2013

Journal Articles

High Resource Utilizers From The Multicenter Compact Study Of Complications In Patients With Sickle Cell Disease and Utilization Of Iron Chelation Therapy

Lanetta B Jordan, MD, MPH, MSPH, Patricia Adams-Graves, MD, Julie Kanter-Washko, MD, Patricia A Oneal, MD, Medha Sasane, BPharm, PhD, Francis Vekeman, MA, Christine Bieri, MBA, Andrea Marcellari, MS, MT(ASCP), Matthew Magestro, MBA, MS, Abigail Adams, BA, Mei S. Duh, ScD, MPH

Blood (2013) 122 (21): 982.

https://doi.org/10.1182/blood.V122.21.982.982

Published: 2013

Journal Articles

Utilization Patterns of Iron Chelation Therapy in Transfusion-Dependent Myelodysplastic Syndrome Patients Enrolled in Medicare Part D.

Amer M. Zeidan, MD, Maria R. Baer, M.D., Steven D. Gore, MD, Medha Sasane, BPharm, PhD, Carole Paley, MD, Diane L. McNally, BSPharm, M.S., Amy J. Davidoff, M.S., Ph.D.

Blood (2012) 120 (21): 3178.

https://doi.org/10.1182/blood.V120.21.3178.3178

Published: 2012

Journal Articles

Age-Related Emergency Department Reliance and Healthcare Resource Utilization in Patients with Sickle Cell Disease

Morey A. Blinder, MD, Francis Vekeman, MA, Medha Sasane, BPharm, PhD, Alex Trahey, BS, Carole Paley, MD, Matthew Magestro, MBA, MS, Mei S. Duh, ScD, MPH

Blood (2012) 120 (21): 475.

https://doi.org/10.1182/blood.V120.21.475.475

Published: 2012

Journal Articles

Final Results From the Multicenter Compact Study of Complications in Patients with Sickle Cell Disease and Utilization of Iron Chelation Therapy: A Retrospective Medical Records Review.

Lanetta B Jordan, MD, MPH, MSPH, Patricia Adams-Graves, MD, Julie Kanter-Washko, MD, Patricia Ann Oneal, MD, Francis Vekeman, MA, Christine Bieri, MBA, Medha Sasane, BPharm, PhD, Andrea Marcellari, MS, MT(ASCP), Matthew Magestro, MBA, MS, Zachary Gorn, BA, Mei S. Duh, ScD, MPH

Blood (2012) 120 (21): 2106.

https://doi.org/10.1182/blood.V120.21.2106.2106

Published: 2012

Journal Articles

Deferasirox Is Associated with Reduced Mortality Risk in a Medicare Population with Myelodysplastic Syndromes

Amer M. Zeidan, MD, Franklin Hendrick, B.S., Erika Friedmann, PhD, Steven D. Gore, MD, Maria R. Baer, M.D., Medha Sasane, BPharm, PhD, Carole Paley, MD, Diane L. McNally, BSPharm, M.S., Amy J. Davidoff, M.S., Ph.D.

Blood (2012) 120 (21): 426.

https://doi.org/10.1182/blood.V120.21.426.426

Published: 2012

Journal Articles

Age-Related Iron Chelation Utilization and Healthcare Costs in Patients with Sickle Cell Disease (SCD)

Morey A. Blinder, MD, Francis Vekeman, MA, Alex Trahey, BA, Medha Sasane, PhD, Carole S. Paley, MD, Mei Sheng Duh, MPH, ScD

Blood (2011) 118 (21): 338.

https://doi.org/10.1182/blood.V118.21.338.338

Published: 2011

Journal Articles

Age-Related Blood Transfusion Patterns in Patients with Sickle Cell Disease (SCD) and the Association with Sickle Cell Complications

Morey A. Blinder, MD, Francis Vekeman, MA, Alex Trahey, BA, Medha Sasane, PhD, Carole S. Paley, MD, Mei Sheng Duh, MPH, ScD

Blood (2011) 118 (21): 12.

https://doi.org/10.1182/blood.V118.21.12.12

Published: 2011

Journal Articles

Costs, Persistence, and Hospitalizations Associated with the Use of Iron-Chelating Therapies in Sickle Cell Disease in Medicaid Patients

Edward P Armstrong, Pharm.D, Grant H Skrepnek, PhD, Samir K. Ballas, MD, Peter Kwok, Pharm.D, Susan Snodgrass, MD, Medha Sasane, PhD

Blood (2011) 118 (21): 3152.

https://doi.org/10.1182/blood.V118.21.3152.3152

Published: 2011

NARROW

Treatment Patterns and Healthcare Resource Utilization in Patients with Multiple Myeloma and Baseline Renal Impairment

Epidemiologic and Clinical Characteristics of Thalassemia (Thal) Intermedia (TI) in the United States

Adherence to Iron Chelation Therapy and Associated Healthcare Resource Utilization and Costs in Medicaid Patients with Sickle Cell Disease

Medical Complications In Patients With Myelofibrosis By Frequency Of Blood Transfusion and Iron Chelation Therapy

Transition From Pediatric To Adult Care Of High Cost Patients In a Medicaid Population With Sickle Cell Disease

High Resource Utilizers From The Multicenter Compact Study Of Complications In Patients With Sickle Cell Disease and Utilization Of Iron Chelation Therapy

Utilization Patterns of Iron Chelation Therapy in Transfusion-Dependent Myelodysplastic Syndrome Patients Enrolled in Medicare Part D.

Age-Related Emergency Department Reliance and Healthcare Resource Utilization in Patients with Sickle Cell Disease

Final Results From the Multicenter Compact Study of Complications in Patients with Sickle Cell Disease and Utilization of Iron Chelation Therapy: A Retrospective Medical Records Review.

Deferasirox Is Associated with Reduced Mortality Risk in a Medicare Population with Myelodysplastic Syndromes

Age-Related Iron Chelation Utilization and Healthcare Costs in Patients with Sickle Cell Disease (SCD)

Age-Related Blood Transfusion Patterns in Patients with Sickle Cell Disease (SCD) and the Association with Sickle Cell Complications

Costs, Persistence, and Hospitalizations Associated with the Use of Iron-Chelating Therapies in Sickle Cell Disease in Medicaid Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only